AFMD Stock Price and Chart — BX:AFMD — TradingView

AFMD Stock Price and Chart — BX:AFMD — TradingView

Overview

Financials News Ideas Forecast

AFMD chart

Upcoming earnings

Key stats

About Affimed N.V.

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs. It operates through the Germany and USA geographical segments. The company was founded in 2000 and is headquartered in Mannheim, Germany.

Financials

Performance

Revenue to profit conversion

Debt level and coverage

Earnings

Next:—

‪0.00‬

Ideas

See all ideas

News

Technicals

Summarizing what the indicators are suggesting.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Neutral

SellBuy

Strong sellStrong buy

Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Interactive Brokers

4.4Very Good

4.4Very Good

See all brokers

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on BX exchange AFFIMED N V stocks are traded under the ticker AFMD.

We've gathered analysts' opinions on AFFIMED N V future price: according to them, AFMD price has a max estimate of 23.12 CHF and a min estimate of 4.58 CHF. Watch AFMD chart and read a more detailed AFFIMED N V stock forecast: see what analysts think of AFFIMED N V and suggest that you do with its stocks.

Yes, you can track AFFIMED N V financials in yearly and quarterly reports right on TradingView.

AFFIMED N V is going to release the next earnings report on Aug 8, 2024. Keep track of upcoming events with our Earnings Calendar.

AFMD earnings for the last quarter are −1.49 CHF per share, whereas the estimation was −1.51 CHF resulting in a 1.50% surprise. The estimated earnings for the next quarter are −1.16 CHF per share. See more details about AFFIMED N V earnings.

AFFIMED N V revenue for the last quarter amounts to ‪486.69 K‬ CHF despite the estimated figure of ‪744.68 K‬ CHF. In the next quarter revenue is expected to reach ‪612.16 K‬ CHF.

AFMD net income for the last quarter is ‪−18.29 M‬ CHF, while the quarter before that showed ‪−24.26 M‬ CHF of net income which accounts for 24.58% change. Track more AFFIMED N V financial stats to get the full picture.

No, AFMD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

As of Jun 2, 2024, the company has 78.00 employees. See our rating of the largest employees — is AFFIMED N V on this list?

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AFFIMED N V EBITDA is ‪−99.76 M‬ CHF, and current EBITDA margin is ‪−1.32 K‬%. See more stats in AFFIMED N V financial statements.

Like other stocks, AFMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AFFIMED N V stock right from TradingView charts — choose your broker and connect to your account.